Your institution may have access to this item. Find your institution then sign in to continue.
Title
Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals
Authors
Collette, Laurence; Burzykowski, Tomasz; Carroll, Kevin J.; Newling, Don; Morris, Tom; Schröder, Fritz H.
Publication
Journal of Clinical Oncology, 2005, Vol 23, Issue 25, p6139